Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$5,542 Mln
Revenue (TTM)
$1,388 Mln
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
45.8
P/B Ratio
3.9
Industry P/E
73.74
EV/EBITDA
19.6
Div. Yield
0 %
Debt to Equity
0.5
Book Value
$--
EPS
$2
Face value
--
Shares outstanding
59,099,500
CFO
$975.40 Mln
EBITDA
$893.07 Mln
Net Profit
$349.43 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Merit Medical Systems (MMSI)
| -3.9 | -5.9 | -7.7 | 15.2 | 21.4 | 16.4 | 15.7 |
|
BSE Sensex*
| 4.0 | -1.2 | 8.0 | 5.3 | 16.6 | 18.9 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Merit Medical Systems (MMSI)
| 27.1 | 7.6 | 13.4 | 12.2 | 77.8 | -44.1 | 29.0 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Merit Medical Systems (MMSI)
|
93.0 | 5,541.8 | 1,387.9 | 122.3 | 13.3 | 8.9 | 45.8 | 3.9 |
| 13.3 | 8,960.8 | 6,685.2 | 715.6 | 16.4 | 12.3 | 12.6 | 1.5 | |
| 250.1 | 6,628.2 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 232.0 | 6,318.9 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 0.9 | |
| 38.4 | 5,823.4 | 3,446.1 | 79.6 | 7.5 | 4.4 | 72.5 | 3.2 | |
| 57.4 | 7,968.4 | 2,510.8 | 185.6 | 8.8 | 4.5 | 43.7 | 1.9 | |
| 71.1 | 8,845.4 | 12,669.0 | 407.0 | 5.4 | 11.8 | 22 | 2.7 | |
| 162.8 | 8,812.8 | 1,973.6 | -494.5 | -11.4 | -41 | -- | 9.3 | |
| 257.0 | 10,106.3 | 1,240.1 | 42.2 | 4.1 | 3.6 | 243.8 | 8.2 | |
| 117.5 | 7,084.1 | 645.7 | -25.4 | 6.8 | -1.3 | -- | 3.6 |
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and... Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah. Address: 1600 West Merit Parkway, South Jordan, UT, United States, 84095 Read more
Founder, Chairman, CEO & President
Mr. Fred P. Lampropoulos
Founder, Chairman, CEO & President
Mr. Fred P. Lampropoulos
Headquarters
South Jordan, UT
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Merit Medical Systems Inc (MMSI) stood at $ 2,665 Mln as on 31-Mar-25
The share price of Merit Medical Systems Inc (MMSI) is $92.95 (NASDAQ) as of 18-Jun-2025 16:00 EDT. Merit Medical Systems Inc (MMSI) has given a return of 21.37% in the last 3 years.
Merit Medical Systems Inc (MMSI) has a market capitalisation of $ 5,542 Mln as on 18-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Merit Medical Systems Inc (MMSI) is 3.88 times as on 18-Jun-2025, a 11% premium to its peers’ median range of 3.49 times.
The P/E ratio of Merit Medical Systems Inc (MMSI) is 45.76 times as on 18-Jun-2025, a 38% discount to its peers’ median range of 73.74 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Merit Medical Systems Inc (MMSI) and enter the required number of quantities and click on buy to purchase the shares of Merit Medical Systems Inc (MMSI).
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah. Address: 1600 West Merit Parkway, South Jordan, UT, United States, 84095
The CEO & director of Mr. Fred P. Lampropoulos. is Merit Medical Systems Inc (MMSI), and CFO & Sr. VP is Mr. Fred P. Lampropoulos.
There is no promoter pledging in Merit Medical Systems Inc (MMSI).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
981
|
|
|
921
|
|
|
906
|
|
|
889
|
|
|
823
|
|
|
742
|
|
|
671
|
|
|
671
|
|
|
602
|
| Merit Medical Systems Inc. (MMSI) | Ratios |
|---|---|
|
Return on equity(%)
|
8.89
|
|
Operating margin(%)
|
13.28
|
|
Net Margin(%)
|
8.81
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Merit Medical Systems Inc (MMSI) was $0 Mln.
$0.05
(
